Researchers have developed a personalized neurological footprint, which uses a link between brain physiology, genetic profile and response to therapeutics, to predict the effectiveness of aiming treatment at various targets within individual patients.
Scientists have demonstrated how variations in a gene linked to anxiety and depression could affect a patient’s response to treatment.
In an international collaboration, researchers have determined that psychiatric disorders may have important molecular similarities that are not reflected in current diagnostic categories.
Scientists have identified novel genes associated with a specific form of schizophrenia, which could potentially aid diagnosis and development of treatments.
A novel study reveals that the placenta could play an imperative role in schizophrenia and possibly other neurodevelopmental disorders.
Researchers have uncovered three new genes that are linked to the possibility of developing Alzheimer’s disease; potentially unlocking new treatment possibilities for patients.
A preliminary study has revealed that an investigational drug may help increase protein levels in babies with spinal muscular atrophy.
A research team has identified a gene that, upon elimination, could potentially spur regeneration of axons in nerve cells severed by spinal cord injury.
Prof Spires-Jones chats to Lauren Pulling about synapse degeneration in Alzheimer’s, as well as the importance of mentoring in science.
Clinical trial announcements, orphan-drug designation and more: check out our round-up of the biggest news from the neuroscience and neurology industries this week.